02/24/2026
The FDA has issued labeling updates for certain FDA-approved menopausal hormone therapy products reflecting changes to long-standing warning language following a review of available evidence. These updates contribute to ongoing, informed discussions around hormone therapy in clinical practice.
WP Pharma Labs partners with healthcare providers to compound prescription-based BHRT formulations, including pellets and creams, developed with an emphasis on precision manufacturing, quality systems, and reliable supply.
Advance care. Maintain flexibility. Partner with WP Pharma Labs.
Learn more today! https://wppharmalabs.
